Duox2 was expressed in only a limited number of normal tissues, none of which demonstrated strong (3+) expression, compared to the cancers, where 73% of the prostate adenocarcinomas were 3+ in expression, and 24% of breast, colon and lung cancers were 3+. The gene discussed is DUOX2; the disease is lung carcinoma.